Since 2000, Everest Biotech has been designing a catalogue containing thousands of goat antibodies against a broad range of human, mouse and rat proteins of biomedical interest.
Prostate cancer is the second most common cancer in men, with skin cancer being the first. If diagnosed early, it can be treated with surgery or radiation therapy, often alongside hormone therapy. Immunohistochemistry (IHC) is used for the diagnosis of prostate carcinoma from prostate biopsy. For this process several IHC prostate cancer biomarkers are used, including Prostate Specific Antigen (PSA), Alpha-methylacyl-CoA racemase (AMACR) and ERG. With the importance of biomarkers such as these, it is hoped that the discovery of new biomarkers will enable improvements to both early detection and treatments.
EB07673 (8µg/ml) staining of paraffin embedded Human Prostate. Heat induced antigen retrieval with citrate buffer pH 6, HRP-staining.EB07673 Negative Control showing staining of paraffin embedded Human Prostate, with no primary antibody.EB09833 Immunofluorescence analysis of paraformaldehyde fixed HEK293 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing strong nuclear and weak cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).
Direct contact technical support
Find products for your research
